Insider Trading Arrangements |
3 Months Ended |
|---|---|
|
Mar. 31, 2024
shares
| |
| Trading Arrangements, by Individual | |
| Rule 10b5-1 Arrangement Adopted | false |
| Non-Rule 10b5-1 Arrangement Adopted | false |
| Non-Rule 10b5-1 Arrangement Terminated | false |
| Bobak Azamian [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | In May 2023, Bobak Azamian, Chief Executive Officer, adopted a Rule 10b5-1 trading plan to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The plan provided for the sale of up to 291,000 shares of common stock held by Dr. Azamian between August 23, 2023 and July 24, 2024. Dr. Azamian terminated the trading plan effective January 8, 2024.
|
| Name | Bobak Azamian |
| Title | Chief Executive Officer |
| Rule 10b5-1 Arrangement Terminated | true |
| Termination Date | January 8, 2024 |
| Aggregate Available | 291,000 |
| Jose Trevejo [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | In May 2023, Jose Trevejo, former Chief Medical Officer, adopted a Rule 10b5-1 trading plan to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The plan provided for the sale of up to 6,107 shares of common stock held by Dr. Trevejo between August 17, 2023 and May 16, 2024. Dr. Trevejo terminated the trading plan effective January 12, 2024.
|
| Name | Jose Trevejo |
| Title | former Chief Medical Officer |
| Rule 10b5-1 Arrangement Terminated | true |
| Termination Date | January 12, 2024 |
| Aggregate Available | 6,107 |